Failure of critical protein connection at heart of cardiomyopathy

f years, it weakens the connection to the cell membrane. You literally beat your heart to death, he said.

The harder and faster the heart beats, the more likely it is to destroy the infrastructure of the myocardium (heart muscle), said Towbin. You put the heart to rest and it reconnects the end of the dystrophin molecule to the membrane.

In the studies with patients on the ventricular assist device, the Baylor team found that after four to six weeks on the pump, 90 percent of them saw a reduction in the number of cells with the defective dystrophin-membrane connection.

A second possible cause of the problem is that a chemical produced by the process of heart failure might target that portion of the dystrophin attached to the contractile apparatus and cell membrane, literally severing it at that critical link, suggested Bowles and Towbin.

Whatever the reason for the dystrophin problem, the finding has important implications for the development of new therapies for cardiomyopathy. The possibility that heart function can be restored in some patients raises the question as to whether some patients would be able to avoid transplantation, they said. Implanting a total artificial heart requires removal of the persons own heart, eliminating the possibility that it could be restored to near normal function by rest with the support of the pump.

However, Towbin and Bowles wonder if their finding indicates that the dilated cardiomyopathy will recur. If you take patients out of the heart failure state now, will they develop dilated cardiomyopathy again in the future? said Towbin.


Contact: Lori Williams/Ron Gilmore
Baylor College of Medicine

Page: 1 2

Related biology news :

1. Failure of DNA repair mechanism precedes final stage of deadly leukemia, new Penn study shows
2. Failures in primate cloning may signal impossibility of human reproductive cloning
3. Immunex And Wyeth-Ayerst Laboratories Advance Enbrel Into Phase II/III Clinical Trial For Chronic Heart Failure
4. Duke Scientist Reports Advances In Gene Therapy For Heart Failure
5. Local Approaches To Combating Antibiotic Resistance Are Doomed To Failure
6. Circulatory Device -- A Bridge To Recovery For Heart Failure?
7. Molecular Key To Heart Failure Development
8. Gene-Altered Mice Boost Studies of Cardiomyopathy: Enables Research Into Causes And Treatment Of Heart Failure
9. Possible Trigger For Heart Failure Identified In Lab Animal Studies
10. UCSD team determines cellular stress within body is critical
11. Carnegie Mellon U biologists identify critical player in yeast ribosome assembly

Post Your Comments:

(Date:8/26/2018)... ... August 24, 2018 , ... ... However, this technology introduces many well-described challenges around data processing, storage and ... London NHS Genomic Medicine Centre. The Viapath Genetics Laboratories have implemented automated, ...
(Date:8/23/2018)... ... August 21, 2018 , ... ... of diverse cell types and species for the robust functional interrogation of complex ... the development of T-cell based immunotherapies, the study of the autoimmunity, the understanding ...
(Date:8/21/2018)... ... 20, 2018 , ... When designing a fluidic system for ... ensure what is designed can be manufactured reliably and cost effectively while meeting ... path design with specific focus on layered manifold technology. , Layered manifold technology ...
Breaking Biology News(10 mins):
(Date:9/12/2018)... ... September 11, 2018 , ... ... add flat sheet Forward Osmosis (FO) membranes from Fluid Technology Solutions (FTS H2O) ... by FTS H2O are constructed from cellulose triacetate (CTA) material. The highly hydrophilic ...
(Date:9/7/2018)... ... 06, 2018 , ... Flagship Biosciences’ MuscleMap algorithm that supports ... as effective as manual pathology. The study, “Validation of a Muscle-Specific Tissue Image-Analysis ... in the Archives of Pathology & Laboratory Medicine on August 31, 2018. Download ...
(Date:8/29/2018)... ... 2018 , ... Nanovis , an innovative and fast-growing ... a $5.5 million funding round managed by Commenda Securities. Key investors include Elevate ... Ventures. , “Our investment in Nanovis is consistent with our mission to support ...
(Date:8/29/2018)... BARBARA, Calif. (PRWEB) , ... August 28, 2018 , ... ... optimization firm for the life sciences and healthcare industries, announces that Manu Vohra will ... on August 30th. , What: “How to Implement Box for GxP in 30 ...
Breaking Biology Technology:
Cached News: